2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol
C23H20F2N6O2 — CID 146591773
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol
2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol (PubChem CID 146591773) has the molecular formula C23H20F2N6O2 and a molecular weight of 450.45 g/mol. Its IUPAC name is 2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol.
Molecular Properties
| Compound Name | 2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol |
|---|---|
| PubChem CID | 146591773 |
| Molecular Formula | C23H20F2N6O2 |
| Molecular Weight | 450.45 g/mol |
| Exact Mass | 450.16 |
| IUPAC Name | 2-[6-[(1S)-1-(2-amino-6,8-difluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-ylindazol-1-yl]ethanol |
| SMILES | C[C@H](Oc1cc2cc(F)cc(F)c2nc1N)c1cc2c(cnn2CCO)cc1-n1cccn1 |
| InChI | InChI=1S/C23H20F2N6O2/c1-13(33-21-9-14-7-16(24)10-18(25)22(14)29-23(21)26)17-11-19-15(12-28-31(19)5-6-32)8-20(17)30-4-2-3-27-30/h2-4,7-13,32H,5-6H2,1H3,(H2,26,29)/t13-/m0/s1 |
| InChIKey | UZCKRJIOGJHZBC-ZDUSSCGKSA-N |
| XLogP | 3.76 |
| TPSA | 104.01 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.45 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146591773 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.